The study evaluated the effect of the carotenoid-rich
extract from
cantaloupe melon (CE) nanoencapsulated in porcine gelatin (EPG) on
hepatic retinol concentration and liver damage scores in Wistar rats
with obesity induced by high glycemic index and high glycemic load
diet (HGLI diet). For 17 days, animals were fed the HGLI diet. They
were divided into three groups and treated for 10 days [HGLI diet
+ water, HGLI diet + CE (12.5 mg/kg), and HGLI diet + EPG (50 mg/kg)].
The groups were evaluated for dietary intake, retinol, weight variation,
hematological parameters, fasting glucose, lipid profile, hepatic
retinol concentration, AST/ALT ratio, FIB-4 (Fibrosis-4 Index for
Liver Fibrosis), and APRI (AST to Platelet Ratio Index) scores to
evaluate the effects on the liver. Animals treated with EPG showed
a lower dietary intake (p < 0.05). No significant
weight change was detected in the evaluated groups (p > 0.05). The EPG-treated group had significantly higher concentrations
(p < 0.05) of hepatic retinol [266 (45) μg/g]
than the untreated group [186 (23.8) μg/g] and the one treated
with CE [175 (8.08) μg/g]. Liver damage assessment scores did
not show significant differences, but the lowest means were observed
in the group treated with EPG. The nanoencapsulation of the extract
rich in beta-carotene promoted reduced food consumption and increased
hepatic retinol without causing significant changes in liver damage
scores. Thus, EPG is a candidate for future clinical studies to evaluate
the beneficial effects of treating diseases involving vitamin A deficiencies.